Stock Ticker

  • Loading stock data...

Novan Inc (NASDAQ:NOVN) Recruits 525 Patients in the Phase 3 Clinical Trial to Treat Molluscum Contagiosum and Expects Topline Results in Q2 2021

Novan Inc (NASDAQ:NOVN) enrolled 525 patients for Simple4 Phase 3 clinical trial. It exceeds 60% enrollment of 825 patients and expects to complete the process in Q1 2021. Treatment for contagious skin infection The main aim of phase 3 clinical trial is to obtain topline efficacy results of the antiviral gel – SB206 to cure […]

Novan Inc. (NASDAQ:NOVN) Has Around $17 Million To Fund Phase 3 SB206 Trial In Molluscum

Novan Inc. (NASDAQ: NOVN) announced that it expects its current cash to be adequate for funding the additional third phase pivotal SB206 study in treating patients with molluscum or B-SIMPLE4. Novan has almost 17 million for conducting phase 3 SB206 trial Since the beginning of June, Novan has secured around $16.9 million from common shares […]